cgp 35348 has been researched along with Substance Withdrawal Syndrome in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dehpour, AR; Karimian, SM; Mirzaii-Dizgah, I; Riahi, E; Roodsari, HR; Sadeghipour, HR | 1 |
| Ghasemi, T; Hajimashhadi, Z; Karimian, SM; Mirzaii-Dizgah, I; Riahi, E | 1 |
| Little, HJ; Mead, AJ | 1 |
| Humeniuk, RE; Ong, J; White, JM | 1 |
| Bonci, A; Williams, JT | 1 |
| Mousa-Ahmadi, E; Zarrindast, MR | 1 |
6 other study(ies) available for cgp 35348 and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Attenuation of morphine withdrawal signs by a GABAB receptor agonist in the locus coeruleus of rats.
Topics: Analysis of Variance; Animals; Baclofen; Dose-Response Relationship, Drug; Drug Therapy, Combination; GABA Agonists; GABA Antagonists; Injections, Subcutaneous; Locus Coeruleus; Male; Morphine; Morphine Dependence; Motor Activity; Naloxone; Narcotic Antagonists; Narcotics; Organophosphorus Compounds; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 2009 |
Attenuation of morphine withdrawal signs by muscimol in the locus coeruleus of rats.
Topics: Animals; Behavior, Animal; Bicuculline; Dose-Response Relationship, Drug; GABA Agonists; GABA Antagonists; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; GABA-B Receptor Antagonists; Locus Coeruleus; Male; Morphine Dependence; Muscimol; Naloxone; Narcotic Antagonists; Organophosphorus Compounds; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 2008 |
Do GABAB receptors have a role in causing behavioural hyperexcitability, both during ethanol withdrawal and in naive mice?
Topics: Animals; Baclofen; Behavior, Animal; Ethanol; GABA-B Receptor Agonists; GABA-B Receptor Antagonists; Handling, Psychological; Male; Mice; Mice, Inbred Strains; Motor Activity; Organophosphorus Compounds; Receptors, GABA-B; Substance Withdrawal Syndrome | 1995 |
The effects of GABAB ligands on alcohol withdrawal in mice.
Topics: Animals; Baclofen; Behavior, Animal; Diazepam; Dose-Response Relationship, Drug; Ethanol; Female; GABA Antagonists; GABA-B Receptor Antagonists; Mice; Mice, Inbred C57BL; Organophosphorus Compounds; Phenylalanine; Receptors, GABA-B; Seizures; Substance Withdrawal Syndrome; Tremor | 1994 |
Increased probability of GABA release during withdrawal from morphine.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dopamine; Dopamine Antagonists; Enzyme Activation; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; Guinea Pigs; Interneurons; Morphine; Nerve Tissue Proteins; Organophosphorus Compounds; Patch-Clamp Techniques; Phorbol 12,13-Dibutyrate; Picrotoxin; Receptors, GABA-A; Salicylamides; Serotonin; Signal Transduction; Staurosporine; Strychnine; Substance Withdrawal Syndrome; Tegmentum Mesencephali; Thionucleotides | 1997 |
Effects of GABAergic system on naloxone-induced jumping in morphine-dependent mice.
Topics: Animals; Baclofen; Behavior, Animal; Bicuculline; GABA Agonists; GABA Antagonists; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Injections, Intraventricular; Male; Mice; Morphine Dependence; Muscimol; Naloxone; Narcotic Antagonists; Organophosphorus Compounds; Picrotoxin; Substance Withdrawal Syndrome | 1999 |